Clinical Trial

FAPI-PET for Tumor Detection

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2023 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective observational trial investigating correlation with histopathology, positive predictive value, detection rate, reproducibility and impact on clinical management of 68-Ga-FAPI PET/CT or PET/MRI in patients receiving this imaging modality for tumor staging or restaging as part of clinical care.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-09-24; most recent amendment 2023-11-28.
Trial Details
NCT Number NCT04571086
Lead Sponsor University Hospital, Essen
Conditions Malignant Neoplasm
Enrollment 500 participants
Start Date 2020-04-30
Primary Completion 2026-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2023-11-29